natriuretic-peptide--c-type and Bone-Diseases

natriuretic-peptide--c-type has been researched along with Bone-Diseases* in 3 studies

Reviews

1 review(s) available for natriuretic-peptide--c-type and Bone-Diseases

ArticleYear
C-type natriuretic peptide and overgrowth.
    Endocrine development, 2009, Volume: 14

    Natriuretic peptides are a family of structurally related peptides with different distinct biological effects. C-type natriuretic peptide (CNP)-mediated signaling is important for endochondral ossification and intervenes in the control of chondrocyte maturation by regulating the balance between proliferation and terminal differentiation. CNP is encoded by the NPPC gene on human chromosome 2 for which, so far, no mutations have been described in humans. Recently, two independent articles reported the description of 3 patients with a similar clinical phenotype characterized by the presence of skeletal anomalies and overgrowth. In all 3 cases, the clinical picture was associated with the presence of a balanced translocation involving chromosome 2 and causing overexpression of the NPPC gene and an increased plasma concentration of its product, CNP. Transcriptional dysregulation of NPPC has been ascribed to the separation of the gene unit from the long-range regulatory element with a transcriptional silencing effect on its expression and CNP overproduction has been correlated to the skeletal overgrowth phenotype observed.

    Topics: Animals; Bone Development; Bone Diseases; Growth Disorders; Humans; Natriuretic Peptide, C-Type; Phenotype

2009

Other Studies

2 other study(ies) available for natriuretic-peptide--c-type and Bone-Diseases

ArticleYear
N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma.
    Biomarkers in medicine, 2015, Volume: 9, Issue:7

    To examine whether N-terminal proCNP concentrations in serum is associated with bone destruction in patients with multiple myeloma.. N-terminal proCNP and biochemical bone markers were measured in 153 patients. Radiographic bone disease and skeletal-related events were evaluated at specific time-points.. N-terminal proCNP concentrations increased with age. High N-terminal proCNP concentrations were associated with high-risk disease and renal impairment. Renal function explained 22% of the variation. N-terminal proCNP concentrations correlated with serum bone ALP and serum PINP, but lacked association with bone resorption markers, radiographic bone disease and skeletal-related events.. Serum N-terminal proCNP are associated with bone formation activity in patients with multiple myeloma, but should be interpreted with caution in patients with renal impairment.

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Diseases; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Natriuretic Peptide, C-Type; Prognosis; Protein Precursors; Radiography

2015
N-terminal C-type natriuretic propeptide is associated with the endosteal apposition of bone in females with a persistent eating disorder.
    Hormone research in paediatrics, 2010, Volume: 74, Issue:3

    Females with anorexia nervosa (AN) are often affected by osteoporosis. The study intends to investigate the association between serum levels of the N-terminal propeptide of the C-type natriuretic peptide (NT-proCNP) and bone development in anorexic females.. In a catamnestic visit, 21 females, formerly treated for AN, were assessed for the presence of eating disorders and analyzed for bone parameters of the distal radius (4% site) with peripheral quantitative computed tomography (pQCT), for maximal isometric grip force (MIGF) and for NT-proCNP serum levels.. The 9 females with a persistent eating disorder had lower height and weight than the recovered girls. NT-proCNP was correlated with the cortical area (r = 0.521), the endosteal circumference (CE, r = -0.468) and the ratio of MIGF to cross-sectional bone area (r = 0.434). CE explained 40% of the variance of NT-proCNP in females with persistent eating disorders, but was not associated with NT-proCNP in recovered girls (p = 0.691). The association between CE and NT-proCNP was not existent when the correlation was controlled for the duration of amenorrhea and the supplemented cumulative dose of ethinylestradiol (p = 0.275).. NT-proCNP reflects metaphyseal inwaisting which is modified by estrogens and the pressure on the growth plate.

    Topics: Adolescent; Anorexia Nervosa; Bone Diseases; Female; Humans; Natriuretic Peptide, C-Type

2010